JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 11 October 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01571-06v1
81/1/272    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abend, J. R.
Right arrow Articles by Imperiale, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abend, J. R.
Right arrow Articles by Imperiale, M. J.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01571-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Inhibitory effect of IFN-{gamma} on BK virus gene expression and replication

Johanna R. Abend, Jonathan A. Low, and Michael J. Imperiale*

Department of Microbiology and Immunology, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA

* To whom correspondence should be addressed. Email: imperial{at}umich.edu.


   Abstract

BK virus (BKV) is widely accepted to be the causative agent of polyomavirus nephropathy. In immunocompromised individuals, especially kidney transplant recipients, BKV can replicate in kidney epithelial cells, causing loss of renal function and eventual destruction of the graft. Advances in immunosuppressive therapies may be partially responsible for the increasing incidence of polyomavirus nephropathy among transplant recipients by more effectively eliminating components of the immune system, such as IFN-{gamma}-producing lymphocytes, that keep BKV infections at a subclinical level. In this study, we investigated the role of IFN-{gamma} in regulating lytic infection by BKV. Treatment with IFN-{gamma} inhibited the expression of the viral early protein, large tumor antigen (TAg), and the late protein, VP1, in a dose-dependent manner. We detected a 1.6- and 12-fold reduction in TAg transcripts at 48 and 96 hours post-infection, respectively, with 250 U/ml IFN-{gamma} treatment, suggesting that IFN-{gamma}-mediated inhibition occurs at the level of transcription. Furthermore, IFN-{gamma} inhibited the level of viral progeny production by as much as 50-fold at an MOI of 0.5 and 80-fold at an MOI of 0.1. The inhibitory effect of IFN-{gamma} was similar for three different strains of BKV examined. These results indicate an important role for IFN-{gamma} in regulating BKV lytic infection.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.